Completed from United Kingdom
The Programa De Desenvolvimento Executivo Em Farmacoeconomia (Advanced) delivered exactly what I was looking for. The curriculum aligned perfectly with my goal to master cost‑effectiveness analysis for new therapies. I especially appreciated the detailed module on incremental cost‑utility ratios, which enabled me to run a full economic evaluation of an oncology drug using the provided Excel templates. The course materials were up‑to‑date, with peer‑reviewed articles and real‑world case studies from the UK NHS. The combination of live webinars and interactive forums made the learning experience professional and highly engaging. I left the program confident that I can now advise senior managers on reimbursement strategies, and I would recommend it without hesitation.
I took the advanced pharmacoeconomics course because I wanted some solid, practical tools to help my team at a biotech startup. The vibe was laid‑back but the content was spot on. I learned how to build a budget impact model from scratch – the step‑by‑step video walkthroughs and the downloadable Excel sheets made it super easy to follow. One of the best parts was the case study on a US‑based specialty drug, which gave me a realistic look at pricing negotiations. The reading pack was concise and relevant, and the instructor was quick to answer questions in the discussion board. Overall, I’m happy with the skills I gained and feel better equipped to support my company's market access plans.
Wow! This course was exactly what I needed to take my career to the next level. The enthusiastic teaching style kept me hooked from day one, and the practical assignments – like creating a health‑technology assessment report for a diabetes medication used in India – gave me hands‑on experience. I was able to apply the new knowledge immediately, presenting a cost‑effectiveness analysis to my senior management team, which resulted in the approval of a new pricing strategy. The course materials were vibrant, with real‑world examples from Asian markets, and the weekly live Q&A sessions felt like a collaborative workshop. I’m thrilled with the results and can’t wait to use these skills in future projects.
The Advanced Executive Programme in Pharmacoeconomics was a thoroughly detailed learning journey. Each module was clearly outlined: starting with the fundamentals of health economics, moving through advanced cost‑benefit analysis, and concluding with strategic decision‑making for emerging markets. I particularly valued the segment on adapting pharmacoeconomic models to African health systems, which included data sets from South Africa and Kenya. The course provided high‑quality PDFs, interactive dashboards, and weekly seminars that deepened my understanding of pricing, reimbursement, and value‑based contracts. By the end of the program I could independently construct a price‑volume forecast for a new vaccine, a skill that directly supports my role in the national procurement unit. The experience was rigorous yet rewarding, and I feel well‑prepared for upcoming policy initiatives.
